HarmonixThe Imperative of Growth Capital for Biotech and Deep Tech in EuropeBy Krish Ramadurai, Partner at HarmonixJan 18Jan 18
HarmonixThe New Era of Programmable BiologyBy Krish Ramadurai, Partner at HarmonixNov 14, 2023Nov 14, 2023
HarmonixThe convergence of biosciences and computation: The Global Effort in Accelerating the 5th…By Krish Ramadurai, Partner at HarmonixOct 11, 2023Oct 11, 2023
HarmonixInsilico MedicineA belated congratulations to one of our legacy fund’s outstanding portfolio companies, Insilico Medicine. They’ve developed the world’s…Sep 20, 2021Sep 20, 2021
HarmonixCaresyntax closes 130M roundhttps://caresyntax.com/news/digital-surgery-leader-caresyntax-extends-series-c-to-total-raise-of-130-million-blackrock-funds-and-proassuranc…Sep 20, 2021Sep 20, 2021
HarmonixHarmonix and CityRock co-invest in AI Startup Sorcero, closing their round on US 10Mhttps://techcrunch.com/2021/09/16/ai-startup-sorcero-secures-10m-for-language-intelligence-platform/?guccounter=1Sep 20, 2021Sep 20, 2021
HarmonixThe Biotech to Techbio Shift: The Next Generation of Data-Enabled Scientific Breakthroughs by Krish…https://medium.com/bioeconomy-xyz/the-biotech-to-techbio-shift-the-next-generation-of-data-enabled-scientific-breakthroughs-bc8dc86f8b42May 3, 2021May 3, 2021
HarmonixMedTech Outlook features our article on The Computational Data Paradigm and the Rise of the…https://startups.medicaltechoutlook.com/cxoinsight/the-computational-data-paradigm-and-the-rise-of-the-bioplatform-nwid-1436.htmlJan 21, 2021Jan 21, 2021
